Could early lipid screening in High-Risk kids prevent future heart attacks?

NCT ID NCT07716488

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study screens children and adolescents aged 5 to 18 who have chronic conditions like congenital heart disease, inflammatory bowel disease, celiac disease, or rheumatic diseases for lipid metabolism disorders. Participants provide a blood sample and complete a questionnaire about lifestyle and family history. The goal is to find out how common high cholesterol and related conditions are in this high-risk group, so that early treatment can be offered and future heart disease may be prevented.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could establish routine lipid screening for high-risk children, enabling early treatment to prevent future heart attacks and strokes.
What could go wrong
This is an observational screening study, not a treatment trial. It may not change outcomes if follow-up care is inconsistent or if screening proves impractical in routine settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CELIAC DISEASE IN ADOLESCENTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University Hospital Jena

    RECRUITING

    Jena, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.